Integrative western and chinese medicine on coronary heart disease: Where is the orientation?

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Li, Siming ^a,b   Xu, Hao ^b  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b XIYUAN HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; ALANINE; ARACHIDONIC ACID; CARDIOVASCULAR AGENT; DIGITALIS; FERULIC ACID; GINSENOSIDE RG 1; GLUCOSE; LACTIC ACID; OLEIC ACID; STEARIC ACID; TETRAMETHYLPYRAZINE; TOXIN; UNCLASSIFIED DRUG; UREA; XS 0601; XUEZHIKANG;

ACANTHOPANAX; ACONITE; ACUTE CORONARY SYNDROME; ALLIUM; ASTHENIA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHINESE MEDICINE; CIRCULATION; CLINICAL EFFECTIVENESS; CROSS-SECTIONAL STUDY; DRUG SAFETY; FOLLOW UP; GARLIC; GINKGO BILOBA; GINSENG; GOOD CLINICAL PRACTICE; HEART INFARCTION; HEMOSTASIS; HERB DRUG INTERACTION; HUMAN; HYPERICUM PERFORATUM; INTEGRATIVE MEDICINE; ISCHEMIC HEART DISEASE; LIPID METABOLISM; NON COMMUNICABLE DISEASE; NONHUMAN; ORIENTATION; PATHOGENESIS; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTENOSIS; REVIEW; SALVIA MILTIORRHIZA; STEM CELL TRANSPLANTATION; THROMBOSIS; TRICHOSANTHES; YIN DEFICIENCY;

EID: 84884240422     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/459264     Document Type: Review

References (53)

1. Chen K. J., Blood stasis syndrome and its treatment with activating blood circulation to remove blood stasis therapy. Chinese Journal of Integrative Medicine 2012 18 12 891 896
2. Xu H., Shi D.-Z., Yin H.-J., Blood-stasis and toxin causing catastrophe hypothesis and acute cardiovascular events: proposal of the hypothesis and its clinical significance. Chinese Journal of Integrated Traditional and Western Medicine 2008 28 10 934 938 2-s2.0-77949626848
3. Shi D.-Z., Xu H., Yin H.-J., Zhang J.-C., Chen K.-J., Combination and transformation of toxin and blood stasis in etiopathogenesis of thrombotic cerebrocardiovascular diseases. Journal of Chinese Integrative Medicine 2008 6 11 1105 1108 2-s2.0-56849114847 10.3736/jcim20081102
4. Wen C., Xu H., Huang Q.-F., Effect of drugs for promoting blood circulation on blood lipids and inflammatory reaction of atherosclerotic plaques in ApoE gene deficiency mice. Journal of Chinese Integrative Medicine 2005 25 4 345 349 2-s2.0-27744563031
5. Zhou M.-X., Xu H., Chen K.-J., et al E. A., Effects of some active ingredients of Chinese drugs for activating blood circulation and detoxicating on blood lipids and atherosclerotic plaque inflammatory reaction in ApoE-gene knockout mice. Chinese Journal of Integrated Traditional and Western Medicine 2008 28 2 126 130 2-s2.0-56149102983
6. Xu H., Qu D., Zheng F., Clinical manifestations of "blood-stasis and toxin" in patients with stable coronary heart disease. Chinese Journal of Integrated Traditional and Western Medicine 2010 30 22 125 129
7. Feng Y., Xu H., Qu D., Zheng F., Shi D.-Z., Chen K.-J., Study on the tongue manifestations for the blood-stasis and toxin syndrome in the stable patients of coronary heart disease. Chinese Journal of Integrative Medicine 2011 17 5 333 338 2-s2.0-79960124721 10.1007/s11655-011-0615-4
8. Xue M., Yin H. J., Wu C. F., Effect of Chinese drugs for activating blood circulation and detoxifying on indices of thrombosis, inflammatory reaction, and tissue damage in a rabbit model of toxin-heat and blood stasis syndrome. Chinese Journal of Integrative Medicine 2013 19 1 42 47
9. Chen K. J., Shi D. Z., Xu H., The criterion of syndrome differentiation and quantification for stable coronary heart disease caused by etiological toxin of Chinese medicine. Chinese Journal of Integrated Traditional and Western Medicine 2011 31 3 313 314
10. Wang X., Hu D. Y., Clinical study on the hypothesis of 'endogenous collateral wind'on acute coronary syndrome. China Journal of Traditional Chinese Medicine and Pharmacy 2008 23 3 204 208
11. Zhong J. B., Dong S. Y., Wang J., Literature analysis on syndrome elements of 2689 patients with angina pectoris. Chinese Journal of Information on TCM 2006 13 5 100 101
12. Zhou J. X., Tang M., Li J., Analysis of Chinese syndrome features and combination laws of 2029 patients with coronary heart disease angina. Chinese Journal of Integrated Traditional and Western Medicine 2011 31 6 753 755
13. Wu H.-L., Ruan X.-M., Yang X.-B., Analysis on TCM syndrome distribution laws in 319 patients with coronary heart disease. Chinese Journal of Integrated Traditional and Western Medicine 2007 27 6 498 500 2-s2.0-58149097454
14. Wang X. C., Nong Y. B., Lin Q., Analysis on the combination characteristics of TCM syndromes of 138 cases with coronary heart disease. Journal of Traditional Chinese Medicine 2008 49 1 62 63
15. Wang L., Liu H. X., Zou Z. D., Research on TCM syndrome characteristics of hospitalized patients with acute myocardial infarction in TCM hospitals of Beijing. Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease 2008 6 4 379 380
16. Wang J., Xing Y. W., Yao K. W., Study on Chinese medicine syndrome elements of coronary heart disease angina pectoris and its clinical applications. Journal of Hubei College of Traditional Chinese Medicine 2009 11 3 3 5
17. Ren Y., Wu Y., Zhang M. Z., Study on Chinese medicine syndromes characteristics and distribution rule around percutaneous coronary intervention perioperative period. Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease 2010 8 6 639 641
18. Yu G. R., He Y. Q., Guo Y. G., Clinical studies on relationship of traditional Chinese medicine syndrome of Coronary heart disease with insulin resistance, lipids and erythrocyte membrane atpase. Journal of Traditional Chinese Medicine 2002 41 2 111 112
19. Wei D. X., Liu M., Pang Y. C., Study on the correlation between Chinese medicine syndrome types and blood lipid levels in patients with coronary heart disease. Journal of Emergency in Traditional Chinese Medicine 2010 19 3 441 442
20. Shi G., Liu T., Clinical epidemiological investigation on Chinese medicine syndrome in patients with Coronary heart disease. Chinese Archives of Traditional Chinese Medicine 2007 25 8 1675 1676
21. Bai C.-J., Zhou Y., Wang L., Zhang D.-L., Yang Y., Delamination of cardiovascular risk factor, staging and grading of hypertension and the changing characteristics of blood lipids and hemorheological indexes in hypertensive patients with different syndromes of traditional Chinese medicine. Chinese Journal of Clinical Rehabilitation 2005 9 23 145 147 2-s2.0-27744592976
22. Xing Y. W., Wang J., Gao Y. H., Study on characters of TCM syndrome and pathological changes of coronary artery in patients of coronary artery disease combined with diabetes. Chinese Journal of Information on TCM 2007 14 9 20 21
23. Ren Y., Zhang M. Z., Chen K. J., You S., Li J., Guo L., Wang L., Clinical and epidemiological investigation of TCM syndromes of patients with coronary heart disease in China. Evidence-Based Complementary and Alternative Medicine 2012 2012 5 2-s2.0-84859768465 10.1155/2012/714517 714517
24. Fu C. G., Gao Z. Y., Wang P. L., Study on the diagnostic criteria for coronary heart disease patients of blood stasis syndrome. Chinese Journal of Integrated Traditional and Western Medicine 2012 32 9 1285 1286
25. Mei L. J., Xiong S. Q., Wang T., A case control study of influential factors for the Han population with coronary heart disease of blood stasis syndrome in Fuzhou area. Chinese Journal of Integrated Traditional and Western Medicine 2012 32 2 168 171
26. Li O., Xu H., The occurrence of cardiovascular events of coronary heart disease inpatients and study on Chinese medicine syndrome distribution laws. Chinese Journal of Integrated Traditional and Western Medicine 2012 32 5 603 606
27. Li S. W., Study on evolution rule of Chinese medicine syndrome in stable phase of coronary heart disease [Ph.D. thesis] 2011 Beijing, China Beijing University of Traditional Chinese Medicine
28. Yu X. T., Zhang L., Xu H., Progress in research on relevant factors affectingTCM syndrome differentiation of CHD. Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease 2009 7 5 581 584
29. Ma X.-J., Yin H.-J., Chen K.-J., Investigation of gene expression profiles in patients with blood stasis syndrome. Journal of Chinese Integrative Medicine 2008 6 4 355 360 2-s2.0-42549117173 10.3736/jcim20080406
30. Yuan Z. K., Wang L. P., Huang X. P., The screening and the functional pathway analysis of differential genes correlated with coronary heart disease of blood stasis syndrome. Chinese Journal of Integrated Traditional and Western Medicine 2012 32 10 1314 1318
31. Wu H. J., Ma Z. C., Gao Y., Study on GAP in blood-stasis type of coronary heart disease by using proteomic technique. Chinese Journal of Integrated Traditional and Western Medicine 2005 3 3 189 191
32. Li X. F., Jiang Y. R., Gao Z. Y., Screening, identification and analysis of platelet differential functional proteins in patients with coronary heart disease of blood-stasis pattern. Chinese Journal of Integrated Traditional and Western Medicine 2010 30 5 467 473
33. Zhao H.-H., Hou N., Wang W., Study on proteomic specificity of unstable angina with qi deficiency and blood stasis syndrome. Chinese Journal of Integrated Traditional and Western Medicine 2009 29 6 489 492 2-s2.0-79952087497
34. Lu X. Y., Xu H., Li G., Zhao T., Study on correspondence between prescription and syndrome and the essence of phlegm and blood stasissyndrome in coronary heart disease based on metabonomics. Chinese Journal of Integrative Medicine 2012 10.1007/s11655-012-1182-z
35. Jian W. X., Yuan Z. K., Huang X. P., Detection and analysis on plasma metabolomics in patient with coronary heart disease of xin-blood stasis syndrome pattern. Chinese Journal of Integrative Medicine 2010 30 6 579 584
36. Lu Z., Kou W., Du B., Wu Y., Zhao S., Brusco O. A., Morgan J. M., Capuzzi D. M., Effect of xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. American Journal of Cardiology 2008 101 12 1689 1693 2-s2.0-44749084870 10.1016/j.amjcard.2008.02.056
37. Chen K.-J., Shi D.-Z., Xu H., Lü S.-Z., Li T.-C., Ke Y.-N., Zhang M.-Z., Lu X.-Y., Sun R.-Y., You S.-J., XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China. Chinese Medical Journal 2006 119 1 6 13 2-s2.0-33644989276
38. Shang Q.-H., Xu H., Lu X.-Y., Wen C., Shi D.-Z., Chen K.-J., A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of senile patients. Chinese Journal of Integrative Medicine 2011 17 9 669 674 2-s2.0-84856012024
39. Tian F., Xie Y.-M., Real-world study: a potential new approach to effectiveness evaluation of traditional Chinese medicine interventions. Journal of Chinese Integrative Medicine 2010 8 4 301 306 2-s2.0-77950915265 10.3736/jcim20100401
40. Gao Z.-Y., Xu H., Shi D.-Z., Wen C., Liu B.-Y., Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine. Journal of Ethnopharmacology 2012 141 2 578 583 2-s2.0-80053174403 10.1016/j.jep.2011.08.071
41. Luo J., Xu H., Outcome measures of Chinese herbal medicine for coronary heart disease: an overview of systematic reviews. Evidence-Based Complementary and Alternative Medicine 2012 2012 9 927392 10.1155/2012/927392
42. Schulz K. F., Altman D. G., Moher D., CONSORT Group, CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Annals of Internal Medicine 2010 152 11 726 732 2-s2.0-77953395873
43. Qiu Y., Xu H., Shi D., Traditional chinese herbal products for coronary heart disease: an overview of cochrane reviews. Evidence-Based Complementary and Alternative Medicine 2012 2012 5 2-s2.0-84859716140 10.1155/2012/417387 417387
44. Xu H., Chen K.-J., Herb-drug interaction: an emerging issue of integrative medicine. Chinese Journal of Integrative Medicine 2010 16 3 195 196 2-s2.0-78149421985 10.1007/s11655-010-0195-z
45. Wald N. J., Law M. R., A strategy to reduce cardiovascular disease by more than 80%. British Medical Journal 2003 326 7404 1419 1423 2-s2.0-0038165393
46. Feng Y., Xu H., Chen K. J., Natural polypill xuezhikang: its clinical benefit and potential multicomponent synergistic mechanisms of action in cardiovascular disease and other chronic conditions. Journal of Alternative Complementary Medicine 2012 18 4 318 328
47. Tachjian A., Maria V., Jahangir A., Use of herbal products and potential interactions in patients with cardiovascular diseases. Journal of the American College of Cardiology 2010 55 6 515 525 2-s2.0-75249084792 10.1016/j.jacc.2009. 07.074
48. Xu H., Chen K.-J., Making evidence-based decisions in the clinical practice of integrative medicine. Chinese Journal of Integrative Medicine 2010 16 6 483 485 2-s2.0-79952569703 10.1007/s11655-010-0560-7
49. Yan X.-F., Ni Q., Wei J.-P., Xu H., Evidence-based practice method of integrative Chinese and western medicine based on literature retrieval through PICO question and complementary and alternative medicine topics. Chinese Journal of Integrative Medicine 2010 16 6 542 548 2-s2.0-79952546136 10.1007/s11655-010-0570-5
50. Tan Z. Y., Jiang T., Tang C. P., Luo J.-L., Tan H.-T., Chen R.-S., The inhibitory effect of tetramethylpyrazine and ferulate on platelet aggregation. Chinese Journal of New Drugs 2003 12 7 529 531
51. Norol F., Merlet P., Isnard R., Sebillon P., Bonnet N., Cailliot C., Carrion C., Ribeiro M., Charlotte F., Pradeau P., Mayol J.-F., Peinnequin A., Drouet M., Safsafi K., Vernant J.-P., Herodin F., Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. Blood 2003 102 13 4361 4368 2-s2.0-10744229677 10.1182/blood-2003-03-0685
52. Wang N.-Y., Lu C.-J., Chen X.-H., Study on effect of ginsenoside Rg1 in promoting myocardiac vascular endothelial cell regeneration through induction on bone marrow stem cell's migration and differentiation in rabbits of myocardial infarction. Chinese Journal of Integrated Traditional and Western Medicine 2005 25 10 916 919 2-s2.0-38049006573
53. Li L. D., Zhang R. L., Liu C. Y., The effects of Shuanglongfang therapy plus bone marrow mononuclear cells autotransplantation on myocardial infarction in swines. Chinese Journal of New Drugs 2003 12 12 999 1004